HIV/Family planning integration

The International Partnership for Microbicides (IPM) 2017 annual report takes a look at promising woman-centered technologies that could expand women's prevention options and help empower them to protect their sexual and reproductive health on their own terms.

End-user input is critical to inform development of multipurpose prevention technology (MPT) products that prevent HIV and pregnancy.

A number of antiretroviral HIV prevention products are efficacious in preventing HIV infection.

Women with HIV who might become pregnant advised to avoid dolutegravir unless using effective contraception

Want to know more about how the use of hormonal contraceptives might impact acquisition of HIV? Do you have questions about how to communicate with audiences about linkages between hormonal contraceptive use and HIV?

To achieve global health and development goals, experts recommend increased investments and comprehensive interventions

The Guttmacher-Lancet Commission’s report lays out the scope of the unfinished sexual and reproductive health and rights (SRHR) agenda; articulates a bold and evidence-based vision for SRHR that is grounded in human rights; provides an integrated, new definition of SRHR to guide this vis

Injectable contraceptives are popular in sub-Saharan Africa but have high discontinuation rates due partly to the need for provider-administered re-injection.

Written in plain terms and organized for quick review, the popular Family Planning: A Global Handbook for Providers offers clinic-based health care professionals in low- and middle-income countries the latest guidance on providing contraceptive methods. Updated to include expanded contra

HIV affects more women than any other life-threatening infectious agent, and most infections are sexually transmitted.